Market Indices


Latest News

from Piper Sandler issued a price target of $7.00 for...

June 26, 2026   CNTB -2.36%

Ryan MacDonald from Needham issued a price target of $16.00 for...

June 26, 2026   BNED 20.13%

H.C. Wainwright analyst issues BUY recommendation for GOSS on June...

June 26, 2026   GOSS -2.25%

Needham analyst issues BUY recommendation for BNED on June 26,...

June 26, 2026   BNED 20.13%

Piper Sandler analyst issues OVERWEIGHT recommendation for CNTB on June...

June 26, 2026   CNTB -2.36%


Price Targets

from Piper Sandler issued a price target of $7.00 for CNTB on 2026-06-26 09:55:31.The adjusted price target was set to $7.00.At the time of the announcement, CNTB...

June 26, 2026   CNTB -2.36%

Ryan MacDonald from Needham issued a price target of $16.00 for BNED on 2026-06-26 09:21:39.The adjusted price target was set to $16.00.At the time of the announcement, BNED...

June 26, 2026   BNED 20.13%

Keay Nakae from Chardan Capital issued a price target of $3.00 for PRQR on 2026-06-26 00:51:26.The adjusted price target was set to $3.00.At the time of the announcement,

June 25, 2026   PRQR -13.54%

Mike Grondahl from Northland Securities issued a price target of $170.00 for SEZL on 2026-06-25 13:20:54.The adjusted price target was set to $170.00.At the time of the announcement,

June 25, 2026   SEZL 2.81%

from UBS issued a price target of $3.10 for INVE on 2026-06-25 13:18:53.The adjusted price target was set to $3.10.At the time of the announcement, INVE was...

June 25, 2026   INVE -32.25%



Market Movers

Top Gainers (%)
LICN
Lichen International Limi
1.74
38.10%
ARBEW
Arbe Robotics Ltd. Warran
0.03
36.73%
BNED
Barnes & Noble Education,
13.43
20.13%
DRTSW
Alpha Tau Medical Ltd. Wa
2.21
20.12%
THCH
TH International Limited
1.69
16.55%
ORMP
Oramed Pharmaceuticals In
5.00
16.28%
HYPR
Hyperfine, Inc.
1.69
15.75%
DWSN
Dawson Geophysical Compan
4.85
11.49%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP 6.24%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE 0.50%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK 0.03%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN 0.87%